#Patient Identifier	CRDB_ADJ_TXT	CRDB_NOSYSTXT	CRDB_PRIOR_RX	CRDB_BRAINMET	CRDB_ECOG	Other Patient ID	12-245 Part A Consented	12-245 Part C Consented	Diagnosis Age	Sex Reported by DMT	Overall Status Reported by DMT	Overall Survival Months Reported by DMT	Disease Free Status	Disease Free (Months)	Neoplasm Histologic Type Name	CRDB_CONSENT_DATE_DAYS	CRDB_SURVIVAL_STATUS	CRDB_TREATMENT_END_DAYS	CRDB_OFF_STUDY_DAYS	CRDB_BASIC_COMMENTS	Year of Diagnosis	Staging System	Patient's Vital Status	Risk Group	Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage	Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage	American Joint Committee on Cancer Tumor Stage Code	Lvi	Chemotherapy	Chemotherapy Details	Chemotherapy Response	Salvage Chemo	F-Uptime (months)	Igcccg stage	Primary histology	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	PED Age	PED Sex	Pediatric Sample	Treatment	Comments	Primary Tumor Localization Type	Initial Stage	Recurrence	Adjuvant Treatment	Number of Prior Therapies	Primary Radiation Therapy	BRAIN METS	Performance Status	Relapse	Patient Current Age	Race Category	Religion	Sex	Ethnicity Category	Overall Survival Status	Overall Survival (Months)	Pediatric Case Indicator
#Identifier to uniquely specify a patient.	Has the patient received adjuvant systemic therapy?	What is the number of prior systemic therapies (Inclusion of endocrine, cytotoxic, biologic therapies)?	Has the patient received prior radiotherapy?	Does the patient have brain metastases?	What is the patient's ECOG status?	Legacy DMP patient identifier (DMPnnnn)	12-245 Part A Consented Status	12-245 Part C Consented	Age at which a condition or disease was first diagnosed.	Sex Reported by DMT	Overall Status reported by DMT	Overall Survival Months Reported by DMT	Disease free status since initial treatment.	Disease free (months) since initial treatment.	Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.	12-245 consent date.	The patient's survival status.	The patient's 12-245 treatment end date.	The patient's 12-245 off study date.	The basic comments at enrollment for 12-245.	Year of Diagnosis	Staging System.	The survival state of the person.	Risk group.	Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	Lvi	Chemotherapy.	Chemotherapy details	Chemotherapy response	Salvage Chemo	F-Uptime in months.	Igcccg stage	Primary Histology	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	PED Age	PED Sex	Pediatric Sample	Treatment	Comments.	Primary Tumor Localization Type	Initial Stage	Recurrence	Adjuvant treatment.	Number of Prior Therapies	Primary radiation therapy.	Brain Metatstasis	The functional level of the patient based on the Zubrod performance scale.	Relapse.	Patient Current Age	The text for reporting information about race.	Religion	Sex	The text for reporting information about ethnicity.	Overall patient survival status.	Overall survival in months since initial diagonosis.	Indication on whether this case is a pediatric patient or not
#STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	NUMBER	STRING	NUMBER	STRING	NUMBER	STRING	NUMBER	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	NUMBER	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING
#1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	1	1
PATIENT_ID	CRDB_ADJ_TXT	CRDB_NOSYSTXT	CRDB_PRIOR_RX	CRDB_BRAINMET	CRDB_ECOG	OTHER_PATIENT_ID	PARTA_CONSENTED_12_245	PARTC_CONSENTED_12_245	AGE	SEX_DMT	OS_STATUS_DMT	OS_MONTHS_DMT	DFS_STATUS	DFS_MONTHS	HISTOLOGICAL_DIAGNOSIS	CRDB_CONSENT_DATE_DAYS	CRDB_SURVIVAL_STATUS	CRDB_TREATMENT_END_DAYS	CRDB_OFF_STUDY_DAYS	CRDB_BASIC_COMMENTS	YEAR_OF_DIAGNOSIS	STAGING_SYSTEM	VITAL_STATUS	RISK_GROUP	CLIN_N_STAGE	CLIN_M_STAGE	PATH_T_STAGE	LVI	CHEMOTHERAPY	CHEMO_DETAILS	CHEMOTHERAPY_RESPONSE	SALVAGE_CHEMO	FUPTIME_MONTHS	IGCCCG_STAGE	PRIMARY_HISTOLOGY	PATH_N_STAGE	PED_AGE	PED_SEX	PEDIATRIC_SAMPLE	TREATMENT	COMMENTS	PRIMARY_TUMOR_LOCALIZATION_TYPE	INITIAL_STAGE	RECURRENCE	ADJUVANT_TX	NUM_PRIOR_THERAPIES	PRIMARY_RADIATION_THERAPY	BRAIN_METS	ECOG_SCORE	RELAPSE	AGE_CURRENT	RACE	RELIGION	SEX	ETHNICITY	OS_STATUS	OS_MONTHS	PED_IND
P-DMP-P001							YES	NO								16739	Alive																																		49	White	CATHOLIC/ROMAN	Female	Non-Spanish; non-Hispanic	DECEASED	78.082	No
P-DMP-P002							YES	NO								24801	Dead	24920																																	68	White	UNKNOWN	Male	Non-Spanish; non-Hispanic	DECEASED	16.241	No
